首页 | 本学科首页   官方微博 | 高级检索  
检索        


Genome-Wide Association Study of Multiplex Schizophrenia Pedigrees
Authors:Douglas F Levinson  Jianxin Shi  Kai Wang  Sang Oh  Brien Riley  Ann E Pulver  Dieter B Wildenauer  Claudine Laurent  Bryan J Mowry  Pablo V Gejman  Michael J Owen  Kenneth S Kendler  Gerald Nestadt  Sibylle G Schwab  Jacques Mallet  Deborah Nertney  Alan R Sanders  Nigel M Williams  Brandon Wormley  Virginia K Lasseter  Margot Albus  Stephanie Godard-Bauché  Madeline Alexander  Jubao Duan  Michael C O'Donovan  Dermot Walsh  Anthony O'Neill  George N Papadimitriou  Dimitris Dikeos  Wolfgang Maier  Bernard Lerer  Dominique Campion  David Cohen  Maurice Jay  Ayman Fanous  Peter Eichhammer  Jeremy M Silverman  Nadine Norton
Abstract:OBJECTIVE The authors used a genome-wide association study (GWAS) of multiply affected families to investigate the association of schizophrenia to common single-nucleotide polymorphisms (SNPs) and rare copy number variants (CNVs). METHOD The family sample included 2,461 individuals from 631 pedigrees (581 in the primary European-ancestry analyses). Association was tested for single SNPs and genetic pathways. Polygenic scores based on family study results were used to predict case-control status in the Schizophrenia Psychiatric GWAS Consortium (PGC) data set, and consistency of direction of effect with the family study was determined for top SNPs in the PGC GWAS analysis. Within-family segregation was examined for schizophrenia-associated rare CNVs. RESULTS No genome-wide significant associations were observed for single SNPs or for pathways. PGC case and control subjects had significantly different genome-wide polygenic scores (computed by weighting their genotypes by log-odds ratios from the family study) (best p=10-17, explaining 0.4% of the variance). Family study and PGC analyses had consistent directions for 37 of the 58 independent best PGC SNPs (p=0.024). The overall frequency of CNVs in regions with reported associations with schizophrenia (chromosomes 1q21.1, 15q13.3, 16p11.2, and 22q11.2 and the neurexin-1 gene NRXN1]) was similar to previous case-control studies. NRXN1 deletions and 16p11.2 duplications (both of which were transmitted from parents) and 22q11.2 deletions (de novo in four cases) did not segregate with schizophrenia in families. CONCLUSIONS Many common SNPs are likely to contribute to schizophrenia risk, with substantial overlap in genetic risk factors between multiply affected families and cases in large case-control studies. Our findings are consistent with a role for specific CNVs in disease pathogenesis, but the partial segregation of some CNVs with schizophrenia suggests that researchers should exercise caution in using them for predictive genetic testing until their effects in diverse populations have been fully studied.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号